Form 4 for INDP Indaptus Therapeutics, Inc.
Accepted 2021-09-16 00:00:00 ET · period of report 2021-09-14 · accession 0001493152-21-022936 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-16 | 2021-09-14 | INDP | Meckler Jeffrey A | CEO, Dir | P - Purchase | $7.00 | +12.0K | 14.5K | +488% | +$84.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-14 | P | A | 12,000 | $7.00 | 14,460 | D | — | — |